When Business of Cannabis launched in 2017, two of our first interviews were with the team from Strainprint that enables medical cannabis patients to track their cannabis usage and “mindfully medicate” for their specific condition. Since last year, Strainprint continues to innovate. Yesterday in Ottawa, they launched their Strainprint Analytics component – which is comprised of the data garnered from their mobile app – which has more than 400,000 tracked sessions to date and more than 6,000,000 data points. We caught up with Strainprint’s CEO Andrew Muroff and President & CTO David Berg to find out the latest on Strainprint Analytics and the implications for decision making in Ottawa. Make sure to check out previous interviews with Andrew Muroff and David Berg.
Tikun Olam Europe Leads the Change in Greece’s Rapidly Evolving Medical Cannabis Landscape
Earlier this year, Greece became the latest EU country to make medical cannabis products available to patients. In February 2024,...
